Desvenlafaxine-induced worsening of hypertension

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 25, Issue 2, 2013, Pages

  Munoli, Ravindra Neelakanthappa ^a   Praharaj, Samir Kumar ^a   Bhandary, Rajeshkrishna P ^a   Selvaraj, Arun G ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b Research Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CLONAZEPAM; DESVENLAFAXINE; ESCITALOPRAM; HYDROCHLOROTHIAZIDE PLUS LOSARTAN;

ADULT; ANXIETY; BLOOD PRESSURE REGULATION; CASE REPORT; COGNITIVE THERAPY; DEPRESSION; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LETTER; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ANTIDEPRESSIVE AGENTS; ANXIETY; CYCLOHEXANOLS; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED;

EID: 84883304443     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.12030074     Document Type: Letter

References (11)

1. Perry R, Cassagnol M: Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder. Clin Ther 2009; 31:1374-1404
2. Tourian KA, Jiang Q, Ninan PT: Analysis of the effect of desvenlafaxine on anxiety symptoms associated with major depressive disorder: pooled data from 9 short-term, double-blind, placebocontrolled trials. CNS Spectr 2010; 15:187-193
3. Feighner JP: Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 1995; 56:574-579
4. Thase ME: Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3, 744 depressed patients. J Clin Psychiatry 1998; 59:502-508
5. Naranjo CA, Busto U, Sellers EM, et al: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245
6. Liebowitz MR, Tourian KA: Efficacy, safety, and tolerability of desvenlafaxine 50 mg/d for the treatment of major depressive disorder: a systematic review of clinical trials. Prim Care Companion J Clin Psychiatry 2010; 12: PCC.09r00845.
7. Pristiq [package insert]. Madison, NJ, Wyeth-Ayerst, September 2008
8. Bahk WM, Pae CU, Chae JH, et al: Even low-dose treatment of venlafaxine may provoke recurrence of hypertension in an Asian patient? Gen Hosp Psychiatry 2001; 23:232-234
9. Khurana RN, Baudendistel TE: Hypertensive crisis associated with venlafaxine. Am J Med 2003; 115: 676-677
10. Johnson EM, Whyte E, Mulsant BH, et al: Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry 2006; 14:796-802
11. Deecher DC, Beyer CE, Johnston G, et al: Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther 2006; 318:657-665